Fraunhofer-Verbund Life Sciences (VLS)
About Fraunhofer
The international orientation of the group - documented by branches in North America (IME) and China (IBMT) - takes account of the globalization of economic life. Furthermore, a Fraunhofer Center for Translational Medicine is being considered together with the Queensland Institute of Medical Research (QIMR). The Fraunhofer VLS is working on contract research projects for numerous customers in Japan's chemical and pharmaceutical industries. The Fraunhofer Group for Life Sciences (VLS) brings together the biological, biomedical, pharmacological and toxicological expertise of the Fraunhofer-Gesellschaft. The Fraunhofer Institutes for Biomedical Engineering (IBMT), Interfacial Engineering and Biotechnology (IGB), Molecular Biology and Applied Ecology (IME), Toxicology and Experimental Medicine (ITEM), Process Engineering and Packaging (IVV) and Cell Therapy and Immunology (IZI) offer combined expertise in the preventive areas of environmental protection and consumer protection as well as in the regenerative areas of medical therapy and environmental remediation under the motto "Research for human health and the environment". This takes into account new findings from genome, proteome and metabolome research. The range of methods and equipment that the Fraunhofer Group for Life Sciences combines is unparalleled in this concentration.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Employees: 10,001+
- Industry : Biotechnology